BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21733794)

  • 1. [Uterine papillary serous carcinoma].
    Langmár Z; Németh M; Kornya L
    Orv Hetil; 2011 Jul; 152(30):1206-8. PubMed ID: 21733794
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
    Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
    Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in surgical stage I uterine papillary serous carcinoma.
    Havrilesky LJ; Secord AA; Bae-Jump V; Ayeni T; Calingaert B; Clarke-Pearson DL; Berchuck A; Gehrig PA
    Gynecol Oncol; 2007 Jun; 105(3):677-82. PubMed ID: 17355889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine papillary serous cancer: a review of the literature.
    del Carmen MG; Birrer M; Schorge JO
    Gynecol Oncol; 2012 Dec; 127(3):651-61. PubMed ID: 23000148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006.
    Tchabo NE; McCloskey S; Mashtare TL; Andrews C; Singh AK; Mhawech-Fauceglia P; Odunsi K; Lele S; Jaggernauth W
    Gynecol Oncol; 2009 Nov; 115(2):249-56. PubMed ID: 19692115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous metastasis of uterine papillary serous carcinoma presenting as a solitary nodule on the umbilical area.
    Lee WJ; Kang SM; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Acta Derm Venereol; 2009; 89(5):544-5. PubMed ID: 19734994
    [No Abstract]   [Full Text] [Related]  

  • 7. Eleven years: the long and winding road.
    Ramondetta LM; Jhingran A
    Gynecol Oncol; 2007 Nov; 107(2):166-8. PubMed ID: 17950382
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
    Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR;
    Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
    Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE
    Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and treatment-related outcome in patients with uterine papillary serous carcinoma.
    Sagr ER; Denschlag D; Kerim-Dikeni A; Stanimir G; Gitsch G; Gilbert L
    Anticancer Res; 2007; 27(2):1213-7. PubMed ID: 17465265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.
    Low JS; Wong EH; Tan HS; Yap SP; Chua EJ; Sethi VK; Soh LT; Low J; Tay EH; Chew SH
    Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review.
    Growdon WB; Rauh-Hain JJ; Cordon A; Garrett L; Schorge JO; Goodman A; Boruta DM; Horowitz NS; del Carmen MG
    Int J Gynecol Cancer; 2012 Mar; 22(3):417-24. PubMed ID: 22237383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen.
    Lee LJ; Demaria R; Berkowitz R; Matulonis U; Viswanathan AN
    Gynecol Oncol; 2014 Jan; 132(1):65-9. PubMed ID: 24211401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal surgical debulking in uterine papillary serous carcinoma affects survival.
    Patsavas K; Woessner J; Gielda B; Rotmensch J; Yordan E; Bitterman P; Guirguis A
    Gynecol Oncol; 2011 Jun; 121(3):581-5. PubMed ID: 21440290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
    Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE
    Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical management of uterine papillary serous carcinoma.
    Roelofsen T; van Ham MA; de Hullu JA; Massuger LF
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):71-81. PubMed ID: 21166512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine papillary serous carcinoma: patterns of failure and survival.
    Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare gynecologic malignancies.
    Schink JC; Lurain JR
    Curr Opin Obstet Gynecol; 1991 Feb; 3(1):78-90. PubMed ID: 1652301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome.
    Faratian D; Stillie A; Busby-Earle RM; Cowie VJ; Monaghan H
    Int J Gynecol Cancer; 2006; 16(3):972-8. PubMed ID: 16803471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of uterine papillary serous carcinoma.
    Hamilton CA; Kapp DS; Chan JK
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):26-33. PubMed ID: 18197002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.